https://scholars.lib.ntu.edu.tw/handle/123456789/468522
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.author | VIN-CENT WU | en_US |
dc.contributor.author | SHYH-CHYI LO | en_US |
dc.contributor.author | YUH-LIEN CHEN | en_US |
dc.contributor.author | Huang P.-H. | en_US |
dc.contributor.author | CHIA-TI TSAI | en_US |
dc.contributor.author | Liang C.-J. | en_US |
dc.contributor.author | Kuo C.-C. | en_US |
dc.contributor.author | Kuo Y.-S. | en_US |
dc.contributor.author | BAI-CHIN LEE | en_US |
dc.contributor.author | Lin Y.-H. | en_US |
dc.contributor.author | YEN-HUNG LIN | en_US |
dc.contributor.author | Sun Y.-Y. | en_US |
dc.contributor.author | SHUEI-LIONG LIN | en_US |
dc.contributor.author | Chen J.-W. | en_US |
dc.contributor.author | Lin S.-J. | en_US |
dc.contributor.author | KWAN-DUN WU | en_US |
dc.creator | Wu V.-C. ;Lo S.-C. ;Yuh-Lien Chen ;Huang P.-H. ;Tsai C.-T. ;Liang C.-J. ;Kuo C.-C. ;Kuo Y.-S. ;Lee B.-C. ;Wu E.-L. ;Lin Y.-H. ;Sun Y.-Y. ;Lin S.-L. ;Chen J.-W. ;Lin S.-J. ;Wu K.-D. | - |
dc.date.accessioned | 2020-03-03T02:28:39Z | - |
dc.date.available | 2020-03-03T02:28:39Z | - |
dc.date.issued | 2011 | - |
dc.identifier.issn | 0021-972X | - |
dc.identifier.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-80053477934&doi=10.1210%2fjc.2011-1135&partnerID=40&md5=81245201be8d18e2f5afb8b583894300 | - |
dc.identifier.uri | https://scholars.lib.ntu.edu.tw/handle/123456789/468522 | - |
dc.description.abstract | Context: Primary aldosteronism (PA) is associated with a higher incidence of cardiovascular events, probably through mineralocorticoid receptor (MR)-dependent endothelial cell dysfunction, in comparison with essential hypertension (EH). Objective: Our objective was to investigate the number and function of endothelial progenitor cells (EPC) in PA and the relationship with arterial stiffness and disease progression. Design and Setting: We conducted a prospective study of the change of EPC number and outcome of PA patients after treatment at a tertiary medical center. Primary Outcomes: Changes in arterial stiffness and EPC number after treatment and the curability of hypertension were assessed. Patients: A total of 113 PA patients (87 patients diagnosed with aldosterone-producing adenoma, 26 with idiopathic hyperaldosteronism) and 55 patients with EH participated. Results: PA patients had higher arterial stiffness than EH patients (P=0.006), with a lower numbers of circulating EPC and endothelial colony-forming units (P < 0.05). The differences were ameliorated at 6 months after unilateral adrenalectomy or treatment with spironolactone. Expression of MR was identified in the EPC. The number of circulating EPC was inversely correlated with the plasma aldosterone concentration (P = 0.021), arterial stiffness (P = 0.029) and serum high-sensitivity C-reactive protein (P = 0.03). High-dose aldosterone (10 -5 and 10 -6 M) attenuated EPC proliferation and angiogenesis in vitro. Among the 45 patients who underwent unilateral adrenalectomy, 32 (71%) were cured of hypertension. The preoperative number of EPC [log(EPC number percent) >-3.6] predicted the curability of hypertension after adrenalectomy (P = 0.003). Conclusions: The relative deficiency of EPC in PA patients may contribute to aldosterone vasculopathy, which can be reversed by adrenalectomy and spironolactone. High aldosterone levels attenuated EPC proliferation and angiogenesis. Circulating EPC number may be a valuable biomarker to identify PA patients with a high incidence of arterial stiffness and to predict postoperative residual hypertension of aldosterone-producing adenoma. Copyright ? 2011 by The Endocrine Society. | en_US |
dc.relation.ispartof | Journal of Clinical Endocrinology and Metabolism | en_US |
dc.subject.classification | [SDGs]SDG3 | - |
dc.subject.other | aldosterone; alpha adrenergic receptor blocking agent; beta adrenergic receptor blocking agent; C reactive protein; calcium channel blocking agent; diuretic agent; mineralocorticoid receptor; spironolactone; adrenal cortex adenoma; adrenalectomy; adult; aldosterone blood level; angiogenesis; arterial stiffness; article; cell count; cell proliferation; colony forming unit; controlled study; disease course; disease marker; disease severity; endothelial progenitor cell; essential hypertension; female; human; human cell; hyperaldosteronism; in vitro study; major clinical study; male; preoperative period; primary hyperaldosteronism; priority journal; prognosis; prospective study; protein blood level; protein expression; treatment outcome; vascular disease; Adenoma; Adult; Aged; Aldosterone; Apoptosis; Arteries; Biological Markers; C-Reactive Protein; Cell Aging; Cell Count; Cell Proliferation; Disease Progression; Endothelial Cells; Female; Flow Cytometry; Humans; Hyperaldosteronism; Hypertension; Male; Middle Aged; Prognosis; Prospective Studies; Reactive Oxygen Species; Regional Blood Flow; Stem Cells; Treatment Outcome; Vascular Diseases | - |
dc.title | Endothelial progenitor cells in primary aldosteronism: A biomarker of severity for aldosterone vasculopathy and prognosis | en_US |
dc.type | journal article | en |
dc.identifier.doi | 10.1210/jc.2011-1135 | - |
dc.identifier.pmid | 21816781 | - |
dc.identifier.scopus | 2-s2.0-80053477934 | - |
dc.relation.pages | 3175-3183 | en_US |
dc.relation.journalvolume | 96 | en_US |
dc.relation.journalissue | 10 | en_US |
item.openairecristype | http://purl.org/coar/resource_type/c_6501 | - |
item.openairetype | journal article | - |
item.grantfulltext | none | - |
item.cerifentitytype | Publications | - |
item.fulltext | no fulltext | - |
crisitem.author.dept | Internal Medicine | - |
crisitem.author.dept | Internal Medicine-NTUH | - |
crisitem.author.dept | Medicine-NTUCC | - |
crisitem.author.dept | Laboratory Medicine | - |
crisitem.author.dept | Laboratory Medicine-NTUH | - |
crisitem.author.dept | Anatomy and Cell Biology | - |
crisitem.author.dept | Internal Medicine | - |
crisitem.author.dept | Internal Medicine-NTUH | - |
crisitem.author.dept | Internal Medicine | - |
crisitem.author.dept | Internal Medicine-NTUH | - |
crisitem.author.dept | Internal Medicine | - |
crisitem.author.dept | Internal Medicine-NTUH | - |
crisitem.author.dept | Physiology | - |
crisitem.author.dept | Internal Medicine-NTUH | - |
crisitem.author.dept | Internal Medicine | - |
crisitem.author.dept | Integrated Diagnostics and Therapeutics-NTUH | - |
crisitem.author.dept | Internal Medicine | - |
crisitem.author.dept | Internal Medicine-NTUH | - |
crisitem.author.orcid | 0000-0001-7935-0991 | - |
crisitem.author.orcid | 0000-0002-6745-5953 | - |
crisitem.author.orcid | 0000-0002-6498-4008 | - |
crisitem.author.orcid | 0000-0002-4853-8665 | - |
crisitem.author.orcid | 0000-0002-7381-4318 | - |
crisitem.author.orcid | 0000-0001-8153-1441 | - |
crisitem.author.orcid | 0000-0002-1041-5571 | - |
crisitem.author.orcid | 0000-0002-3339-1509 | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
crisitem.author.parentorg | National Taiwan University Cancer Center (NTUCC) | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
顯示於: | 解剖學暨細胞生物學科所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。